NATICK, Mass., April 7 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the first quarter ended March 31, 2006 on Tuesday, April 18, at 11:00 a.m. ET.

The call will be hosted by Jim Tobin, President and Chief Executive Officer, Paul LaViolette, Chief Operating Officer, and Larry Best, Executive Vice President and Chief Financial Officer.

The live webcast and archived replay of this call will be available at http://www.bostonscientific.com/ in the Investor Relations section. The webcast is also being distributed over CCBN's Investor Distribution Network via two locations: CCBN's Individual Investor Center, http://www.earnings.com/, which is accessible to the public, and http://www.streetevents.com/, CCBN's password-protected event management site for CCBN clients.

To ensure a timely connection to the live webcast it is recommended that users register at least 15 minutes before the webcast begins. A replay of the webcast will begin at approximately 12:00 p.m. ET on April 18 and will be available for one year.

A press release will be issued before the market opens on Tuesday, April 18.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com/.

Forward Looking Statements

This press release contains forward-looking statements, including statements as to regulatory approvals for the merger, timing expectations to complete the merger and other statements identified by words such as "anticipates", "believes", "estimates", "expects", "intends", "may", "projects", "plans", "will" and similar expressions intended to identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the satisfaction of other closing conditions contained in the merger agreement and other risk factors relating to our industry as detailed from time to time in each of Boston Scientific's and Guidant's reports filed with the Securities and Exchange Commission, including each such company's most recent Annual Report on Form 10-K. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Unless legally required, Boston Scientific undertakes no obligation to update publicly any forward-looking statements herein, whether as a result of new information, future events or otherwise.

   CONTACT:  Milan Kofol
             508-650-8569
             Investor Relations
             Boston Scientific Corporation

             Paul Donovan
             508-650-8541
             Media Relations
             Boston Scientific Corporation

SOURCE: Boston Scientific Corporation

CONTACT: Milan Kofol, Investor Relations, +1-508-650-8569, or Paul
Donovan, Media Relations, +1-508-650-8541, both of Boston Scientific
Corporation

Web site: http://www.bostonscientific.com/